D051-0309 Screening compound: N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(4-ethylphenoxy)-N~1~-(2-furylmethyl)propanamide

D051-0309 Screening compound: N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(4-ethylphenoxy)-N~1~-(2-furylmethyl)propanamide
D051-0309 Screening compound: N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(4-ethylphenoxy)-N~1~-(2-furylmethyl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D051-0309
N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(4-ethylphenoxy)-N~1~-(2-furylmethyl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D051-0309

Molecular Formula

C20H25NO5S (C20 H25 NO5 S)

Compound Name

N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-2-(4-ethylphenoxy)-N~1~-(2-furylmethyl)propanamide

IUPAC name

N-(11-dioxo-1lambda6-thiolan-3-yl)-2-(4-ethylphenoxy)-N-[(furan-2-yl)methyl]propanamide

SMILES

CCc(cc1)ccc1OC(C)C(N(Cc1ccco1)C(CC1)CS1(=O)=O)=O

InChI

InChI=1S/C20H25NO5S/c1-3-16-6-8-18(9-7-16)26-15(2)20(22)21(13-19-5-4-11-25-19)17-10-12-27(23,24)14-17/h4-9,11,15,17H,3,10,12-14H2,1-2H3

InChI Key

NGALZHVYTLPWRS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04161480

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

391.49

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.712

Distribution Coefficient, logD

2.712

Water Solubility, LogSw

-3.05

Polar Surface Area

58.398

Acid Dissociation Constant (pKa)

20.41

Base Dissociation Constant (pKb)

-4.85

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

45.00

D051-0309 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D051-0309 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D051-0309?
Check Price and Availability of D051-0309, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D051-0309 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D051-0309
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D051-0309
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D051-0309 available by request